Most cited papers from Piramal (India)
What are the most cited papers from Piramal (India)?
The most cited paper from Piramal (India) is "Polymorphs, Salts, and Cocrystals: What’s in a Name?" (Srinivasulu Aitipamula et al., 2012), with 1,053 citations. Next come "Multifunctional dendritic polymers in nanomedicine: opportunities and challenges" (420) and "Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications" (286).
Showing 50 of 61 papers. Every paper with more than 54 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Polymorphs, Salts, and Cocrystals: What’s in a Name? Srinivasulu Aitipamula et al. · Crystal Growth & Design | 12 Apr 2012 | 1,053 |
| 2 | Multifunctional dendritic polymers in nanomedicine: opportunities and challenges Jayant J. Khandare, Marcelo Calderón, Nilesh M. Dagia et al. · Chemical Society Reviews | 13 Dec 2011 | 420 |
| 3 | Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications Shashwat S. Banerjee, Naval D. Aher, Rajesh B. Patil et al. · Journal of Drug Delivery | 7 May 2012 | 286 |
| 4 | Managing protein flexibility in docking and its applications Chandrika B‐Rao, Jyothi Subramanian, Somesh Sharma · Drug Discovery Today | 29 Jan 2009 | 235 |
| 5 | Fermentation, a feasible strategy for enhancing bioactivity of herbal medicines Ahtesham Hussain, Shambhunath Bose, Jing‐Hua Wang et al. · Food Research International | 30 Dec 2015 | 214 |
| 6 | Endophytic fungi: a reservoir of antibacterials Sunil K. Deshmukh, Shilpa Amit Verekar, Sarita V. Bhave · Frontiers in Microbiology | 8 Jan 2015 | 211 |
| 7 | Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFα, IL-1β, NO and MAP kinases B. Gayathri, Nemali Manjula, Kontham Sanathkumar Vinaykumar et al. · International Immunopharmacology | 22 Feb 2007 | 204 |
| 8 | Enhancing Curcumin Oral Bioavailability Through Nanoformulations Vinod S. Ipar, Anisha A. D’souza, Padma V. Devarajan · European Journal of Drug Metabolism and Pharmacokinetics | 15 Feb 2019 | 169 |
| 9 | Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development Gil D. Rabinovici, María C. Carrillo, Mark S. Forman et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions | 20 Sep 2016 | 160 |
| 10 | Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition Velumani Muthusamy, S. Anand, K. Sangeetha et al. · Chemico-Biological Interactions | 25 Apr 2008 | 149 |
| 11 | Benzimidazole: A Milestone in the Field of Medicinal Chemistry Mahesh S. Vasava, Manoj N. Bhoi, Sanjay K. Rathwa et al. · Mini-Reviews in Medicinal Chemistry | 22 Nov 2019 | 140 |
| 12 | Anti‐Inflammatory and Anticancer Activity of Ergoflavin Isolated from an Endophytic Fungus Sunil K. Deshmukh, Prabhu Dutt Mishra, Asha Kulkarni‐Almeida et al. · Chemistry & Biodiversity | May 2009 | 129 |
| 13 | Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series Ravindra Shamrao Pawar, Vijay Gavade, Nivedita Patil et al. · Children | 2 Jul 2021 | 127 |
| 14 | In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00 Kalpana Joshi, Maggie J. Rathos, Rajendra Joshi et al. · Molecular Cancer Therapeutics | Mar 2007 | 122 |
| 15 | Azetidines of pharmacological interest Deepa R. Parmar, Jigar Y. Soni, Ramakrishna Guduru et al. · Archiv der Pharmazie | 29 Jun 2021 | 112 |
| 16 | Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation Gina Mavrikis Cox, Aaron P. Kithcart, David Pitt et al. · The Journal of Immunology | 25 Jun 2013 | 107 |
| 17 | Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-α and IL-6 inhibitors Sandip Bibishan Bharate, Tushar R. Mahajan, Yogesh R. Gole et al. · Bioorganic & Medicinal Chemistry | 27 Jun 2008 | 104 |
| 18 | In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARγ in L6 myotubes R. Anandharajan, S. Jaiganesh, N.P. Shankernarayanan et al. · Phytomedicine | 3 Nov 2005 | 104 |
| 19 | Antibacterial Agents from Actinomycetes - A Review Girish, Badrinath Mahajan · Frontiers in Bioscience-Elite | 26 Oct 2011 | 101 |
| 20 | Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools? Peter Jeffrey Snyder, Kristin Kahle‐Wrobleski, Stephen K. Brannan et al. · Alzheimer s & Dementia | Nov 2014 | 101 |
| 21 | The chemistry, pharmacologic, and therapeutic applications of Polyalthia longifolia Ashish C. Suthar, Vinay Singh Chauhan, K Katkar · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review | 2010 | 101 |
| 22 | Peroxisome proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice Rai Ajit K. Srivastava, Ravi Jahagirdar, Salman Azhar et al. · Molecular and Cellular Biochemistry | 13 Feb 2006 | 97 |
| 23 | A detailed study of developmental immunotoxicity of imidacloprid in Wistar rats Lalita Gawade, Shruta S. Dadarkar, Raghib Husain et al. · Food and Chemical Toxicology | 18 Sep 2012 | 96 |
| 24 | Road traffic congestion monitoring and measurement using active RFID and GSM technology K. Mandal, Arindam Sen, Abhijnan Chakraborty et al. | Oct 2011 | 94 |
| 25 | Some less known ethnomedicinal uses from Mysore and Coorg districts, Karnataka state, India Rajendra Kshirsagar, Neelima Singh · Journal of Ethnopharmacology | May 2001 | 91 |
| 26 | Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells Palak R. Parekh, Leena Motiwale, Nishigandha R. Naik et al. · Experimental and Toxicologic Pathology | 5 Feb 2010 | 87 |
| 27 | Cellular imaging using biocompatible dendrimer-functionalized graphene oxide-based fluorescent probe anchored with magnetic nanoparticles Prateek S. Wate, Shashwat S. Banerjee, Archana Jalota‐Badhwar et al. · Nanotechnology | 25 Sep 2012 | 84 |
| 28 | Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes Sandip Bibishan Bharate, Kumar V.S. Nemmani, Ram Ashrey Vishwakarma · Expert Opinion on Therapeutic Patents | Feb 2009 | 82 |
| 29 | Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor Jonathan E. Wilson, Gaurav K. Patel, Chirag Patel et al. · ACS Medicinal Chemistry Letters | 23 Apr 2020 | 81 |
| 30 | Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies Deepa R. Parmar, Jigar Y. Soni, Ramakrishna Guduru et al. · Bioorganic Chemistry | 27 Jul 2021 | 80 |
| 31 | Preclinical Formulations: Insight, Strategies, and Practical Considerations Sanket M. Shah, Ankitkumar S. Jain, Ritu Kaushik et al. · AAPS PharmSciTech | 11 Jun 2014 | 78 |
| 32 | A review on synthetic investigation for quinoline- recent green approaches Ashish D. Patel et al. · Green Chemistry Letters and Reviews | 3 Apr 2022 | 75 |
| 33 | PEG-conjugated highly dispersive multifunctional magnetic multi-walled carbon nanotubes for cellular imaging Jayant J. Khandare, Archana Jalota‐Badhwar, Sneha D. Satavalekar et al. · Nanoscale | 15 Dec 2011 | 75 |
| 34 | P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models Kalpana Joshi, Maggie J. Rathos, Pravin Mahajan et al. · Molecular Cancer Therapeutics | Mar 2007 | 74 |
| 35 | Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery Geetanjali Chimote, Jayasree Sreenivasan, Nilambari Pawar et al. · Drug Design Development and Therapy | Aug 2014 | 72 |
| 36 | Discrimination and conversion prediction of mild cognitive impairment using convolutional neural networks The Alzheimer’s Disease Neuroimaging Initiative, Congling Wu, Shengwen Guo et al. · Quantitative Imaging in Medicine and Surgery | Nov 2018 | 69 |
| 37 | Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress Jessica K. Alexander, Gina Mavrikis Cox, Jinbin Tian et al. · Experimental Neurology | May 2012 | 69 |
| 38 | Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents Abhay Atmaram Upare, Pradip K. Gadekar, Hariharan Sivaramakrishnan et al. · Bioorganic Chemistry | 9 Feb 2019 | 68 |
| 39 | A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma Ryan Daniel Cassaday, Andre Henri Goy, Suresh Hariram Advani et al. · Clinical Lymphoma Myeloma & Leukemia | 5 Mar 2015 | 68 |
| 40 | Antiarthritic effects of Ajuga bracteosa Wall ex Benth. in acute and chronic models of arthritis in albino rats Gaurav Kaithwas, Raju Gautam, Sanjay M. Jachak et al. · Asian Pacific Journal of Tropical Biomedicine | Mar 2012 | 68 |
| 41 | Modern approaches to a rapid diagnosis of tuberculosis: Promises and challenges ahead Ram Pramod Tiwari, Narendra S. Hattikudur, Ramesh N. Bharmal et al. · Tuberculosis | 7 Oct 2006 | 68 |
| 42 | Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ Monica P. Bubenik et al. · Journal of Medicinal Chemistry | 20 Sep 2022 | 67 |
| 43 | DMSO–POCl3: a reagent for methylthiolation of imidazo[1,2-a]pyridines and other imidazo-fused heterocycles Shashikant Malagoud Patil, Sarang Kulkarni, Malcolm Mascarenhas et al. · Tetrahedron | 12 Jul 2013 | 67 |
| 44 | Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells Sivapriya Ponnurangam, Prasad R. Dandawate, Animesh Dhar et al. · Oncotarget | 11 Dec 2015 | 67 |
| 45 | Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma Noopur S Raje et al. · Leukemia | 8 Jan 2009 | 67 |
| 46 | Discovery of Nanomolar DCAF1 Small Molecule Ligands Alice Shi Ming Li et al. · Journal of Medicinal Chemistry | 22 Mar 2023 | 66 |
| 47 | Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279 Silvana M. Leit et al. · Journal of Medicinal Chemistry | 10 Jul 2023 | 63 |
| 48 | Dysoxylum binectariferum Hook.f (Meliaceae), a rich source of rohitukine Patel Mohanakumara, N. Sreejayan, Vaidayanathan Priti et al. · Fitoterapia | 16 Aug 2009 | 63 |
| 49 | Antiviral potential of selected Indian medicinal (ayurvedic) plants against Herpes Simplex Virus 1 and 2 Priyanka Jadhav, Natasha Kapoor, Becky M. Thomas et al. · North American Journal of Medical Sciences | 2012 | 63 |
| 50 | Synthesis of novel 4-nitropyrrole-based semicarbazide and thiosemicarbazide hybrids with antimicrobial and anti-tubercular activity Rajesh A. Rane, Shital S. Naphade, Pavan Kumar Bangalore et al. · Bioorganic & Medicinal Chemistry Letters | 15 May 2014 | 63 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.